v3.26.1
Fair Value Measurements (Tables)
 12 Months Ended
Dec. 31, 2025
EBP 001  
EBP, Investment, Fair Value and NAV [Line Items]  
EBP, Investment, Fair Value and NAV
The following fair value hierarchy tables present information about each major class/category of the Plan’s investments measured at fair value:
 
Fair value measurements at December 31, 2025, using
 Quoted prices
in active
markets for
identical assets
(Level 1)		Significant
other
observable
inputs
(Level 2)		Significant
unobservable
inputs
(Level 3)		Total
Amgen stock$126,196,526 $— $— $126,196,526 
Cash and cash equivalents339,411 — — 339,411 
Collective trust funds— 722,136,732 — 722,136,732 
Common and preferred stocks8,175,678 — — 8,175,678 
Mutual funds27,612,784 — — 27,612,784 
Self-directed brokerage accounts26,713,652 — — 26,713,652 
Total investments at fair value$189,038,051 $722,136,732 $— $911,174,783 
 
Fair value measurements at December 31, 2024, using
 Quoted prices
in  active
markets  for
identical assets
(Level 1)		Significant
other
observable
inputs
(Level 2)		Significant
unobservable
inputs
(Level 3)		Total
Amgen stock$100,973,506 $— $— $100,973,506 
Cash and cash equivalents43,702 — — 43,702 
Collective trust funds— 577,297,941 — 577,297,941 
Common and preferred stocks47,870,415 — — 47,870,415 
Mutual funds16,198,902 — — 16,198,902 
Self-directed brokerage accounts19,625,736 — — 19,625,736 
Total investments at fair value$184,712,261 $577,297,941 $— $762,010,202